Escitalopram’s Effectiveness in Treating MDD in American Male Adolescents: Meta-Analysis Insights
Reading Time: 2 minutes Introduction Major Depressive Disorder (MDD) represents a significant public health challenge, particularly among American male adolescents, where the condition can often go undiagnosed and untreated. The advent of selective serotonin reuptake inhibitors (SSRIs) has revolutionized the treatment landscape for MDD. Among these, escitalopram has emerged as a prominent therapeutic option. This article delves into a recent meta-analysis that underscores the effectiveness of escitalopram in achieving symptom remission in this demographic, offering renewed hope and a clearer path forward for those affected. Understanding Major Depressive Disorder in Adolescents Major Depressive Disorder is characterized by persistent feelings of sadness and a loss...


